Manufacturing / Pharmaceutical Preparations
Ultragenyx Pharmaceutical Inc.
RARE
$16.34
+$0.20 (+1.24%)
Price as of Nov 3, 2026 13:37 UTC
2.4 B
Market Cap (Mid Cap)
13%
IV Rank
59.9%
Implied Volatility
Nov 03
Next Earnings
Technical Signals
as of Oct 30
Bearish
1 of 7
Trend
- Above 20-day average $15.94
- Above 50-day average $17.55
- Above 200-day average $22.83 · -29.5%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) Down · 43d ago
- Momentum cross (20/50) Down · 61d ago
Volume
- Below-average volume 0.7x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
2.41
Bearish skew
Implied Volatility
59.9%
0% percentile
IV vs Realized
Options cheap
30d HV 175.8%
Options Heat Map
Delta-risk grid for RARE options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
25 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Jun 01, 2026 | Horn Howard | Sell | 4,653 | $110,602 | -31.4% | |
| May 18, 2026 | SULIMAN SHEHNAAZ | Sell | 5,740 | $144,189 | -35.1% | |
| May 14, 2026 | NARACHI MICHAEL | Grant | 14,058 | $0 | -36.8% | |
| May 14, 2026 | SULIMAN SHEHNAAZ | Grant | 14,058 | $0 | -36.8% | |
| May 14, 2026 | Dunsire Deborah | Grant | 7,751 | $0 | -36.8% | |
| May 14, 2026 | SULIMAN SHEHNAAZ | Grant | 7,751 | $0 | -36.8% | |
| May 14, 2026 | Ray Amrit | Grant | 7,751 | $0 | -36.8% | |
| May 14, 2026 | WELCH DANIEL G | Grant | 7,751 | $0 | -36.8% | |
| May 14, 2026 | WELCH DANIEL G | Grant | 14,058 | $0 | -36.8% | |
| May 14, 2026 | Fust Matthew K | Grant | 7,751 | $0 | -36.8% |
Politician Trades in RARE
| Date | Politician | Party | Type | Amount | Since Buy |
|---|---|---|---|---|---|
| Sep 29, 2026 | Gil Cisneros | D | Purchase | $1K-$15K | +5.1% |
| Mar 03, 2026 | Gil Cisneros | D | Purchase | $1K-$15K | -27.1% |
| Feb 18, 2026 | Gil Cisneros | D | Purchase | $1K-$15K | -21.3% |
| Aug 08, 2025 | Gil Cisneros | D | Purchase | $1K-$15K | -41.5% |
| Jul 15, 2025 | Gil Cisneros | D | Purchase | $1K-$15K | -40.8% |
| Jan 21, 2022 | Ro Khanna | D | Sale | $1K-$15K | — |
| Jan 11, 2022 | Ro Khanna | D | Sale | $1K-$15K | — |
| Dec 14, 2021 | Ro Khanna | D | Purchase | $1K-$15K | -80.3% |
| Aug 30, 2021 | Kurt Schrader | D | Purchase | $1K-$15K | -83.2% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Nov 02, 2026 | Q3 2026 | -$1.14 | |||
| Aug 03, 2026 | Q2 2026 | -$1.24 | |||
| Mar 31, 2026 | Q1 2026 | -$1.54 | -$1.84 | -19.5% | Miss |
| Dec 31, 2025 | Q4 2025 | -$1.11 | -$1.29 | -15.8% | Miss |
| Sep 30, 2025 | Q3 2025 | -$1.26 | -$1.81 | -43.7% | Miss |
| Jun 30, 2025 | Q2 2025 | -$1.32 | -$1.17 | +11.7% | Beat |
Track RARE with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for RARE and your entire portfolio.